Royal Bank of Canada
CNST

Royal Bank of Canada’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Royal Bank of Canada’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-461
Closed -$16K – 8185
2021
Q2 		$16K Sell
461
-5,066
-92% -$129K ﹤0.01% 6695
2021
Q1 		$130K Buy
5,527
+3,019
+120% +$91.5K ﹤0.01% 5277
2020
Q4 		$73K Buy
2,508
+1,196
+91% +$30.1K ﹤0.01% 5491
2020
Q3 		$26K Sell
1,312
-1,057
-45% -$25.8K ﹤0.01% 5601
2020
Q2 		$72K Buy
2,369
+625
+36% +$22.5K ﹤0.01% 5045
2020
Q1 		$55K Buy
1,744
+569
+48% +$19.8K ﹤0.01% 5110
2019
Q4 		$55K Sell
1,175
-4,575
-80% -$132K ﹤0.01% 5413
2019
Q3 		$37K Buy
5,750
+5,732
+31,844% +$47.9K ﹤0.01% 5247
2019
Q2 		$0 Buy
+18
New +$200 ﹤0.01% 7346
2019
Q1 		– Sell
-246
Closed -$1K – 7251
2018
Q4 		$1K Buy
246
+130
+112% +$784 ﹤0.01% 6649
2018
Q3 		$1K Buy
+116
New +$1.1K ﹤0.01% 6639

Royal Bank of Canada's CNST Position: Q3 2021 in Review

Royal Bank of Canada sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 461 shares — an estimated $16K sold.

Royal Bank of Canada first reported a position in CNST in Q3 2018 and held it in 11 quarters. The position peaked at $130K in Q1 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Royal Bank of Canada reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Royal Bank of Canada sold 461 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $16K.
  • Royal Bank of Canada first reported a position in Constellation Pharmaceuticals, Inc. in Q3 2018 and held it in 11 quarters.
  • Royal Bank of Canada's Constellation Pharmaceuticals, Inc. position peaked at $130K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Royal Bank of Canada's 13F filing for Q3 2021, filed 15 Nov 2021.